Navigation Links
Codexis Names Wes Bolsen VP and Chief Marketing Officer
Date:12/5/2011

REDWOOD CITY, Calif., Dec. 5, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced Wesley J. Bolsen has been named Vice President and Chief Marketing Officer.  In this new position, Mr. Bolsen will have responsibility for the company's corporate marketing and communications.  He will report to Alan Shaw, Ph.D., President and Chief Executive Officer.

Mr. Bolsen is a widely recognized marketing executive in the global biofuels industry. He joins Codexis from Coskata, where he most recently served as Chief Marketing Officer. While at Coskata from 2007-2011, he also held the senior management positions of Vice President, Government Affairs and Vice President, Business Development.  Previously, he was Chief Financial Officer for ICM, Inc., and a Senior Consultant for McKinsey & Co.

He was named the Top CMO in the United States in 2011 by the Chief Marketing Officer Institute, and is an executive board member of the Renewable Fuels Association, a former board member of the Advanced Biofuels Association and a founding member of the Advanced Ethanol Council. Mr. Bolsen holds a bachelor's degree in electrical engineering from Rose Hulman Institute of Technology and an MBA from the Stanford Graduate School of Business.

"We are very pleased to welcome Wes Bolsen to Codexis," Dr. Shaw said.  "His active leadership role as an advocate in the biofuels industry, combined with his proven expertise in marketing, will be important as Codexis moves towards commercialization of renewable fuels and chemicals products."

Codexis is an industrial biotechnology company producing high value sustainable chemicals, clean fuels, cost effective pharmaceutical processes and renewable bioindustrial ingredients to make industry more efficient, productive and profitable.  Partners include global leaders such as Shell, Merck and Pfizer.  For more information, see www.codexis.com.

 

Contacts:
Media:  Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771; Investors:  Henk Adriaenssens, ir@codexis.com, 650.421.8331

 


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shell Transfers Its Codexis Shares to Raizen
2. Codexis Reports First Quarter 2011 Results
3. Former Senator Byron Dorgan Elected to Codexis Board
4. Codexis Reports Fourth Quarter and Full Year 2010 Results
5. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
6. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
7. Codexis R&D Productivity Panels Also Used By Roche
8. Codexis Names Lori Giver VP Systems Biology
9. Codexis, Teva in Licensing Agreement Final
10. Codexis Names Vice President, Intellectual Property
11. Codexis, Arch Announce Expanded Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2019)... (PRWEB) , ... November 05, 2019 , ... Ole, a German Shepherd, was demonstrating signs ... stairs and jumping. Though his energy level and his willingness to play were normal, ... surgeon Dr. Holly Mullen of VCA Emergency Animal Hospital and Referral Center in ...
(Date:11/2/2019)... ... October 31, 2019 , ... drug360 graph, ... pioneer tellic. drug360 brings tellic’s expertise in biomedical language processing and machine ... quickly uncover relationships between genes, diseases, variants, phenotypes, and other biomedical entities. ...
(Date:10/29/2019)... ... ... CaroGen Corporation , a biotechnology company, today announced three distinguished additions ... Wands, MD, of Brown University , Dr. Steve Projan, PhD, FAAM, formerly ... of Wayne State University, formerly a professor at Yale University School of Medicine ...
(Date:10/26/2019)... , ... October 24, 2019 , ... ... in Bichsel Medical Marketing Group (BMMG), a boutique healthcare-specific marketing firm, ... offerings of its in-house Healthcare Strategy Division. , Healthcare clients in pharma, bio-therapeutics, ...
Breaking Biology Technology:
(Date:10/30/2019)... (PRWEB) , ... October 30, ... ... poly(N-substituted glycine) “peptoids” exhibit self-assembly properties and bioactivity that are encoded by ... Peptoids differ from peptides in the shift of the sidechain attachment to ...
(Date:10/26/2019)... ... October 23, 2019 , ... Medrio is pleased to ... executive leadership team. , As a market leader in solutions for EDC, Direct ... companies to reduce timelines and improve quality with real-time data capture. In ...
(Date:10/26/2019)... ... October 25, 2019 , ... Leak ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is ... detection system, the SIMS Model 1915+ . The SIMS 1915+ unit is ...
Breaking Biology News(10 mins):